Aliases & Classifications for Acute Stress Disorder

MalaCards integrated aliases for Acute Stress Disorder:

Name: Acute Stress Disorder 12 15
Stress Disorders, Traumatic, Acute 71
Stress Disorders, Traumatic 71
Traumatic Stress Disorder 12


External Ids:

Disease Ontology 12 DOID:6088
ICD9CM 34 308.3
UMLS 71 C0029488 C0038441 C0236816

Summaries for Acute Stress Disorder

Disease Ontology : 12 An anxiety disorder that has symptom flashbacks, has symptom bad dreams, has symptom frightening thoughts, has symptom avoidance or has symptom hyperarousal of PTSD occurring within one month of a traumatic experience as Acute Stress Disorder or ASD.

MalaCards based summary : Acute Stress Disorder, also known as stress disorders, traumatic, acute, is related to sleep disorder and alcohol use disorder, and has symptoms including flashbacks, bad dreams and frightening thoughts. An important gene associated with Acute Stress Disorder is CRP (C-Reactive Protein), and among its related pathways/superpathways is Glucocorticoid Pathway (HPA Axis), Pharmacodynamics. The drugs Tramadol and Diazepam have been mentioned in the context of this disorder. Affiliated tissues include brain, eye and testes, and related phenotype is homeostasis/metabolism.

Wikipedia : 74 Acute stress disorder (ASD, also known as acute stress reaction, psychological shock, mental shock, or... more...

Related Diseases for Acute Stress Disorder

Diseases related to Acute Stress Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 291)
# Related Disease Score Top Affiliating Genes
1 sleep disorder 31.1 SLC6A4 CRP BDNF
2 alcohol use disorder 31.0 SLC6A4 CRHR1 CRH BDNF
3 substance abuse 31.0 SLC6A4 CRHR1 CRH BDNF
4 sleep apnea 31.0 SLC6A4 CRP BDNF
5 alexithymia 30.9 SLC6A4 OXT CRP
6 neurotic disorder 30.8 SLC6A4 BDNF
7 fibromyalgia 30.7 SLC6A4 CRP CRH BDNF
8 psychotic disorder 30.6 SLC6A4 OXT CFI BDNF
9 eating disorder 30.6 SLC6A4 CRH BDNF
10 substance dependence 30.6 SLC6A4 CRHR1 CRH BDNF
11 personality disorder 30.5 SLC6A4 NR3C1 FKBP5 CRHR1 CRH BDNF
12 borderline personality disorder 30.4 SLC6A4 NR3C1 FKBP5 CRHR1 CRH BDNF
13 dysthymic disorder 30.3 SLC6A4 CRH CFI BDNF
14 retrograde amnesia 30.3 SLC6A4 BDNF
15 drug dependence 30.3 SLC6A4 CRHR1 CRH BDNF
16 chronic fatigue syndrome 30.3 SLC6A4 NR3C1 CRHR1 CRH
17 tobacco addiction 30.2 SLC6A4 CRHR1 CRH BDNF
18 bulimia nervosa 30.2 SLC6A4 OXT CRH BDNF
19 post-traumatic stress disorder 30.2 SLC6A4 NR3C1 FKBP5 CRP CRHR1 CRH
20 attention deficit-hyperactivity disorder 30.2 SLC6A4 OXT NR3C1 FKBP5 BDNF
21 irritable bowel syndrome 30.2 SLC6A4 CRP CRHR1 CRH BDNF
22 somatization disorder 30.1 SLC6A4 OXT MHRT CRH
23 anorexia nervosa 30.1 SLC6A4 OXT CRH BDNF
24 agoraphobia 30.0 SLC6A4 CRH CFI BDNF
25 panic disorder 30.0 SLC6A4 CRHR1 CRH BDNF
26 dissociative disorder 29.9 SLC6A4 OXT CFI BDNF
27 adjustment disorder 29.9 SLC6A4 CFI BDNF
28 separation anxiety disorder 29.9 SLC6A4 OXT MHRT
29 autism spectrum disorder 29.9 SLC6A4 OXT NR3C1 FKBP5 BDNF
30 leptin deficiency or dysfunction 29.8 OXT CRP CRH BDNF
31 depression 29.7 SLC6A4 CRHR1 CRH BDNF
32 generalized anxiety disorder 29.7 SLC6A4 NR3C1 CRP CRHR1 BDNF
33 mood disorder 29.6 SLC6A4 NR3C1 CRHR1 CRH BDNF
34 hypochondriasis 29.5 SLC6A4 MHRT CFI BDNF
35 obsessive-compulsive disorder 29.4 SLC6A4 OXT FKBP5 CRH BDNF
36 anterograde amnesia 29.4 GABRR3 BDNF
37 schizophrenia 29.4 SLC6A4 OXT NR3C1 FKBP5 CRP CRHR1
38 social phobia 29.4 SLC6A4 OXT MHRT CFI BDNF
39 atypical depressive disorder 29.4 SLC6A4 NR3C1 CRP CRHR1 CRH BDNF
40 postpartum depression 29.4 SLC6A4 OXT NR3C1 CRH BDNF
41 withdrawal disorder 29.3 GABRR3 CRHR1 CRH
42 alcohol dependence 29.3 SLC6A4 OXT CRHR1 CRH BDNF
43 bipolar disorder 29.2 SLC6A4 NR3C1 GABRR3 FKBP5 CRP CRHR1
44 acquired immunodeficiency syndrome 29.2 NR3C1 CRP CRH
45 endogenous depression 29.2 SLC6A4 OXT NR3C1 CRP CRHR1 CRH
46 phobia, specific 29.2 SLC6A4 OXT MHRT CRH CFI
47 migraine with or without aura 1 29.1 SLC6A4 OXT GABRR3 CRP CRHR1 CRH
48 disease of mental health 29.0 SLC6A4 OXT GABRR3 CRP CRHR1 CRH
49 anxiety 28.7 SLC6A4 OXT NR3C1 FKBP5 CRP CRHR1
50 mental depression 28.7 SLC6A4 OXT NR3C1 FKBP5 CRP CRHR1

Comorbidity relations with Acute Stress Disorder via Phenotypic Disease Network (PDN):

Anxiety Hypertension, Essential
Intermediate Coronary Syndrome

Graphical network of the top 20 diseases related to Acute Stress Disorder:

Diseases related to Acute Stress Disorder

Symptoms & Phenotypes for Acute Stress Disorder


  • flashbacks
  • bad dreams
  • frightening thoughts
  • avoidance
  • hyperarousal of ptsd occurring

UMLS symptoms related to Acute Stress Disorder:

agitation, motor restlessness, acute stress/transient/situational disturbance

MGI Mouse Phenotypes related to Acute Stress Disorder:

# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.4 BDNF CFI CRH CRHR1 CRP FAM163A

Drugs & Therapeutics for Acute Stress Disorder

Drugs for Acute Stress Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 316)
# Name Status Phase Clinical Trials Cas Number PubChem Id
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
Diazepam Approved, Illicit, Investigational, Vet_approved Phase 4 439-14-5 3016
Prednisone Approved, Vet_approved Phase 4 53-03-2 5865
Ziprasidone Approved Phase 4 146939-27-7 60854
Risperidone Approved, Investigational Phase 4 106266-06-2 5073
Vortioxetine Approved, Investigational Phase 4 508233-74-7 9966051
Mifepristone Approved, Investigational Phase 4 84371-65-3 55245
Ondansetron Approved Phase 4 99614-02-5 4595
Oxytocin Approved, Vet_approved Phase 4 50-56-6 53477758 439302
Hydromorphone Approved, Illicit Phase 4 466-99-9 5284570
Clonazepam Approved, Illicit Phase 4 1622-61-3 2802
Histamine Approved, Investigational Phase 4 51-45-6 774
Mianserin Approved, Investigational Phase 4 24219-97-4 4184
Haloperidol Approved Phase 4 52-86-8 3559
Dronabinol Approved, Illicit Phase 4 1972-08-3 16078
Memantine Approved, Investigational Phase 4 19982-08-2 4054
Aripiprazole Approved, Investigational Phase 4 129722-12-9 60795
Mirtazapine Approved Phase 4 85650-52-8, 61337-67-5 4205
Asenapine Approved Phase 4 65576-45-6, 85650-56-2 3001386
Levodopa Approved Phase 4 59-92-7 6047
Pimavanserin Approved, Investigational Phase 4 706779-91-1 16058810
Eszopiclone Approved, Investigational Phase 4 138729-47-2 969472
Promethazine Approved, Investigational Phase 4 60-87-7 4927
Suvorexant Approved, Investigational Phase 4 1030377-33-3
Diphenhydramine Approved, Investigational Phase 4 58-73-1, 147-24-0 3100
Bupropion Approved Phase 4 34911-55-2, 34841-39-9 444
Fluvoxamine Approved, Investigational Phase 4 54739-18-3 3404 5324346
Carbon monoxide Approved, Investigational Phase 4 630-08-0 281
Citalopram Approved Phase 4 59729-33-8 2771
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
Fluoxetine Approved, Vet_approved Phase 4 54910-89-3 3386
Sertraline Approved Phase 4 79617-96-2 68617
Propranolol Approved, Investigational Phase 4 525-66-6 4946
Paroxetine Approved, Investigational Phase 4 61869-08-7 43815
Guanfacine Approved, Investigational Phase 4 29110-47-2 3519
Valproic acid Approved, Investigational Phase 4 99-66-1 3121
37 Olive Phase 4
38 Adrenergic Antagonists Phase 4
39 Analgesics, Non-Narcotic Phase 4
40 Dopamine agonists Phase 4
41 Quetiapine Fumarate Phase 4 111974-72-2
42 Hormones Phase 4
43 Hormone Antagonists Phase 4
44 Antitubercular Agents Phase 4
45 Serotonin 5-HT1 Receptor Agonists Phase 4
46 Serotonin 5-HT3 Receptor Antagonists Phase 4
47 Contraceptive Agents Phase 4
48 Contraceptives, Oral Phase 4
49 Contraceptives, Postcoital Phase 4
50 Histamine Antagonists Phase 4

Interventional clinical trials:

(show top 50) (show all 1338)
# Name Status NCT ID Phase Drugs
1 A Prospective Double Blind Randomized Placebo Controlled Trial of Repetitive Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder Unknown status NCT00134446 Phase 4
2 The Effect of 21-Days Intranasal Oxytocin on Clinical Symptoms and Social Function in Patients With Post Traumatic Stress Disorder (PTSD), a Randomized Controled Trail Unknown status NCT02336568 Phase 4 Oxytoine;PLACEBO
3 A Double-Blind, Placebo-Controlled, Flexible-Dose Pilot Clinical Trial of Once-Daily Extended-Release Tramadol for the Treatment of PTSD Unknown status NCT01517711 Phase 4 Tramadol;Placebo
4 Predictors of Treatment Response to Fluoxetine in PTSD Following a Recent History of War Zone Stress Exposure Unknown status NCT00633685 Phase 4 Fluoxetine;Placebo
5 A Randomized Cross Over Trial of Two Treatments for Obstructive Sleep Apnea in Veterans With Post Traumatic Stress Disorder Unknown status NCT01535586 Phase 4
6 Double Blind, Placebo-Controlled Trial of THC as add-on Therapy for PTSD Unknown status NCT00965809 Phase 4 Tetrahydrocannabinol
7 Early Pharmacological Intervention With Diazepam in the Emergency Room Setting to Prevent Posttraumatic Stress Disorder (PTSD). Unknown status NCT01221883 Phase 4 Diazepam
8 Efficacy of an SSRI in Acute Stress Disorder and PTSD Completed NCT00050804 Phase 4 sertraline
9 Neurofunctional Markers of SSRI Treatment Response in PTSD Completed NCT00700999 Phase 4 Paroxetine
10 A Placebo-controlled, Randomized, Double-blind Comparison of Placebo vs Short Course Low Dose Corticosteroids on Posttraumatic Stress Disorder (PTSD) Completed NCT00204737 Phase 4 prednisone;placebo
11 Reducing Suicidal Ideation Through Treatment of Nightmares-PTSD Completed NCT02199652 Phase 4 Prazosin;Placebo
12 Naltrexone and Cognitive-Behavioral Therapy for Patients With Alcoholism and Post-Traumatic Stress Disorder Completed NCT00006489 Phase 4 Naltrexone;Placebo
13 Effects of Escitalopram on Autonomic Reactivity in Post Traumatic Stress Disorder Among Veterans of Operation Enduring Freedom and Iraqi Freedom (OEF/OIF) Completed NCT01271244 Phase 4 Escitalopram
14 Coordinated Anxiety Learning and Management (CALM): Improving Primary Care Anxiety Outcomes Completed NCT00347269 Phase 4 Psychotropic medication optimization
15 Eszopiclone for the Treatment of PTSD Completed NCT01605253 Phase 4 Eszopiclone;Placebo
16 The Outcome of Treatment of Traumatised Refugees With Trauma-Focused Cognitive Behavioural Therapy and / or Antidepressants - a Randomised Controlled Trial Completed NCT00917397 Phase 4 Sertraline
17 Evaluation of the Efficacy of Vortioxetine for Posttraumatic Stress Disorder Completed NCT02637895 Phase 4 Placebo;Vortioxetine
18 Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder Completed NCT00120250 Phase 4 Eszopiclone
19 Cognitive Behavioral Therapy vs. Sertraline in the Treatment of Post Traumatic Stress Disorder Completed NCT00391430 Phase 4 Sertraline
20 Evaluation of the Effects of Low Flow Anesthesia on Pain and Agitation in Patients After Recovery Completed NCT03862391 Phase 4 Analgesics;Antiemetics
21 Prophylaxis of Posttraumatic Stress Disorder With Post-Trauma Propranolol Completed NCT00158262 Phase 4 Propranolol;Placebo
22 Risperidone Monotherapy in the Treatment of PTSD in Women Survivors of Domestic Abuse and Rape Trauma: a Double-Blind, Placebo Controlled, Randomized Clinical Trial Completed NCT00208182 Phase 4 Risperidone
23 Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD) Completed NCT00203463 Phase 4 topiramate
24 The Effect of Intranasal Oxytocin on Emphatic Abilities in Patients With PTSD Completed NCT01325168 Phase 4 syntocinon nasal spray;placebo nasal spray
25 Randomized Trial of Sertraline, Prolonged Exposure, and Their Combination for Post-traumatic Stress Disorder (PTSD) in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF). Completed NCT01524133 Phase 4 Sertraline
26 The Effect of Different Dose of Dexmedetomidine Combined With Hydromorphone in Children With Tonsillectomy and Adenoidectomy Completed NCT03760809 Phase 4 Dexmedetomidine 0.5μg/kg;Dexmedetomidine 1μg/kg
27 Combined Treatment With a Benzodiazepine (Clonazepam) and a Selective Serotonin Reuptake Inhibitor (Paroxetine) for Rapid Treatment of Posttraumatic Stress Disorder (PTSD) Completed NCT00025740 Phase 4 clonazepam and paroxetine
28 The Treatment of Traumatised Refugees With Sertraline Versus Venlafaxine in Combination With Psychotherapy - a Randomised Clinical Study Completed NCT01569685 Phase 4 Venlafaxine;Sertraline
29 A Pilot Study to Assess the Effects of Doxazosin on Polysomnography in PTSD Completed NCT01959022 Phase 4 Doxazosin XL
30 Treatment of Sleep Disturbances in Trauma-affected Refugees: A Randomised Controlled Trial Completed NCT02761161 Phase 4 Mianserin
31 Geodon (Ziprasidone) for Posttraumatic Stress Disorder Completed NCT00208208 Phase 4 Ziprasidone
32 A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Posttraumatic Stress Disorder in Civilians Completed NCT00208130 Phase 4 Topiramate
33 Topiramate Treatment of Alcohol Use Disorders in Veterans With Post Traumatic Stress Disorder (PTSD): A Pilot Controlled Trial of Augmentation Therapy Completed NCT01087736 Phase 4 Topiramate
34 Treatment for Psychogenic Nonepileptic Seizures: A Pilot, 12 Week, Prospective, Randomized, Placebo-controlled, Double-blind, Clinical Trial of Sertraline in the Treatment of Comorbid Psychiatric Disorders in NES Completed NCT00159965 Phase 4 sertraline;placebo
35 Preventing Post-Operative Delirium in Pneumonectomy, Esophagectomy and Thoracotomy Patients Completed NCT02213900 Phase 4 Haloperidol;Placebo
36 Developing Memory Reconsolidation Blockers as Novel PTSD Treatments Completed NCT01490697 Phase 4 Mifepristone;d-Cycloserine;Placebo-matching Mifepristone;Placebo-matching d-Cycloserine (DCS)
37 An Open-Label Trial of Memantine for Cognitive Impairment in Patients With Post-Traumatic Stress Disorder Completed NCT02258828 Phase 4 Memantine;Placebo
38 Atomoxetine in Comorbid ADHD/PTSD: A Pilot, Placebo-Controlled Feasibility Study Completed NCT02287038 Phase 4 Atomoxetine 80 MG
39 Combined Mirtazapine and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment of Post-traumatic Stress Disorder (PTSD) Completed NCT01178671 Phase 4 Mirtazapine;Sertraline
40 Interest for a Relative of Seeing Himself Proposing to Witness Resuscitation of a Family Member Victim of a Cardiac Arrest Completed NCT01009606 Phase 4
41 Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD) Completed NCT00560612 Phase 4 Paroxetine;Placebo
42 Combination Treatment for PTSD After the WTC Attack Completed NCT01130103 Phase 4 Paroxetine
43 Effects of Hydrocortisone and D-Cycloserine on Fear Extinction in Veterans With Posttraumatic Stress Disorder Completed NCT00674570 Phase 4 Hydrocortisone;D-Cycloserine;Placebo
44 An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder Completed NCT01587118 Phase 4 Adjunctive asenapine
45 A Placebo-controlled Trial of Adjunctive Quetiapine for Refractory PTSD Completed NCT00292370 Phase 4 Open Label (OL) Paroxetine;Placebo;Quetiapine
46 Aripiprazole (Abilify) Therapy for Reducing Comorbid Substance Abuse Completed NCT00208169 Phase 4 Aripiprazole
47 Prazosin Treatment for Combat Trauma PTSD Nightmares and Sleep Disturbance Completed NCT00108420 Phase 4 Prazosin
48 Effects of Paxil CR on Neural Circuits in PTSD Completed NCT00672776 Phase 4 paroxetine;placebo
49 A Double-Blind Placebo-Controlled Trial of Prazosin for the Treatment of Alcohol Dependence Completed NCT00167687 Phase 4 prazosin
50 Telemedicine Outreach for Post Traumatic Stress in CBOCs Completed NCT00821678 Phase 4

Search NIH Clinical Center for Acute Stress Disorder

Genetic Tests for Acute Stress Disorder

Anatomical Context for Acute Stress Disorder

MalaCards organs/tissues related to Acute Stress Disorder:

Brain, Eye, Testes, Amygdala, Cortex, Heart, Prefrontal Cortex

Publications for Acute Stress Disorder

Articles related to Acute Stress Disorder:

(show top 50) (show all 11308)
# Title Authors PMID Year
Brain-wide mapping of c-fos expression in the single prolonged stress model and the effects of pretreatment with ACH-000029 or prazosin. 61
32478146 2020
Social support modulates the association between PTSD diagnosis and medial frontal volume in Chinese adults who lost their only child. 61
32490056 2020
Repeated exposure of naïve and peripheral nerve-injured mice to a snake as an experimental model of post-traumatic stress disorder and its co-morbidity with neuropathic pain. 61
32474017 2020
Lower levels of bodily pain increase risk for non-medical use of prescription drugs among current US reserve soldiers. 61
32315933 2020
TLR4/MyD88/NF-κB-Mediated Inflammation Contributes to Cardiac Dysfunction in Rats of PTSD. 61
31939007 2020
Registered clinical trials investigating ketamine for psychiatric disorders. 61
32315806 2020
Riemannian classifier enhances the accuracy of machine-learning-based diagnosis of PTSD using resting EEG. 61
32376342 2020
The Role of Medical Specialization on Posttraumatic Symptoms in Pediatric Nurses. 61
32339973 2020
Ginsenoside Rg1 fails to rescue PTSD-like behaviors in a mice model of single-prolonged stress. 61
32482388 2020
Prevalence and correlates of comorbid PTSD with depression among older people exposed to the Jeju April 3 incident. 61
32379624 2020
The Association Between Sexual Functioning and Suicide Risk in U.S. Military Veteran Couples Seeking Treatment for Post-Traumatic Stress Disorder. 61
31915971 2020
Post-Traumatic Stress Disorder is Associated with further Increased Parkinson's Disease Risk in Veterans with Traumatic Brain Injury. 61
32232880 2020
Increased Vascular Pathology in Older Veterans With a Purple Heart Commendation or Chronic Post-Traumatic Stress Disorder. 61
31426715 2020
Self-concept, post-traumatic self-appraisals and post-traumatic psychological adjustment: what are the relationships? 61
32301403 2020
Patient-related stressful situations and stress-related outcomes in emergency nurses: A cross-sectional study on the role of work factors and recovery during leisure time. 61
32446016 2020
Cannabinoids as therapeutics for PTSD. 61
32311373 2020
Delayed behavioral and genomic responses to acute combined stress in zebrafish, potentially relevant to PTSD and other stress-related disorders: Focus on neuroglia, neuroinflammation, apoptosis and epigenetic modulation. 61
32344037 2020
Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study. 61
31745697 2020
Exogenous effects of oxytocin in five psychiatric disorders: a systematic review, meta-analyses and a personalized approach through the lens of the social salience hypothesis. 61
32348803 2020
Mental health consequences during the initial stage of the 2020 Coronavirus pandemic (COVID-19) in Spain. 61
32405150 2020
Is returning to work during the COVID-19 pandemic stressful? A study on immediate mental health status and psychoneuroimmunity prevention measures of Chinese workforce. 61
32335200 2020
Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry. 61
32353518 2020
Uptrend in distress and psychiatric symptomatology in pregnant women during the coronavirus disease 2019 pandemic. 61
32449178 2020
Assessing the Presence of Post-Traumatic Stress and Turnover Intention Among Nurses Post-Middle East Respiratory Syndrome Outbreak: The Importance of Supervisor Support. 61
32146875 2020
Mental Health of Adolescents in the Era of Antiretroviral Therapy: Is There a Difference Between HIV-Infected and Uninfected Youth in South Africa? 61
32269000 2020
Stress-induced blood brain barrier disruption: Molecular mechanisms and signaling pathways. 61
32275963 2020
Polyvictimization and mental health consequences of female genital mutilation/circumcision (FGM/C) among Somali refugees in Kenya. 61
31711407 2020
The Effectiveness of Using Neurofeedback in the Treatment of Post-Traumatic Stress Disorder: A Systematic Review. 61
29890906 2020
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. 61
32437679 2020
The association between challenging behaviour and symptoms of post-traumatic stress disorder in people with intellectual disabilities: a Bayesian mediation analysis approach. 61
32378249 2020
Development of a Tailored Behavioral Weight Loss Program for Veterans With PTSD (MOVE!+UP): A Mixed-Methods Uncontrolled Iterative Pilot Study. 61
32162528 2020
High and low anxiety phenotypes in a rat model of complex post-traumatic stress disorder are associated with different alterations in regional brain monoamine neurotransmission. 61
32361171 2020
Cannabinoid CB2 receptors mediate the anxiolytic-like effects of monoacylglycerol lipase inhibition in a rat model of predator-induced fear. 61
32375160 2020
Responding to the mental health consequences of the 2015-2016 terrorist attacks in Tunisia, Paris and Brussels: implementation and treatment experiences in the United Kingdom. 61
31769712 2020
Drinking motivations in UK serving and ex-serving military personnel. 61
31961932 2020
Could Combat Stress Affect Journalists' News Reporting? A Psychophysiological Response. 61
32529414 2020
Equine-Assisted Therapy for Veterans with PTSD: Manual Development and Preliminary Findings. 61
32034416 2020
Group II metabotropic glutamate receptor activation in the basolateral amygdala mediates individual differences in stress-induced changes in rapid eye movement sleep. 61
32534177 2020
Postoperative Psychological Disorders Among Heart Transplant Recipients: A Meta-Analysis and Meta-regression. 61
32541547 2020
Mental health status of medical staff in emergency departments during the Coronavirus disease 2019 epidemic in China. 61
32512134 2020
Characteristic patterns of EEG oscillations in sheep (Ovis aries) induced by ketamine may explain the psychotropic effects seen in humans. 61
32528071 2020
Splice-specific deficiency of the PTSD-associated gene PAC1 leads to a paradoxical age-dependent stress behavior. 61
32533011 2020
Right temporal pole volume reduction in PTSD. 61
32084508 2020
Effects of expressive writing intervention for women's PTSD, depression, anxiety and stress related to pregnancy: A meta-analysis of randomized controlled trials. 61
32315889 2020
Evaluating the quality of meta-analytical reviews using the AMSTAR-2: A systematic review of meta-analytical reviews regarding child sexual abuse interventions. 61
32240874 2020
Potentiation of Divergent Medial Amygdala Pathways Drives Experience-Dependent Aggression Escalation. 61
32424020 2020
Factors Associated With Posttraumatic Stress Disorder Among Veterans of Recent Wars Receiving Veterans Affairs Chiropractic Care. 61
32534740 2020
Predictors of Quality of Life Following Cognitive Processing Therapy Among Women and Men With Post-Traumatic Stress Disorder. 61
32077948 2020
Prevalence of Symptoms of Anxiety, Depression, and Post-traumatic Stress Disorder in Parents and Children Following Pediatric Stroke. 61
32202201 2020
Prevalence of Post-Traumatic Stress Disorder Among Asylum Seekers in Italy: A Population-Based Survey in Sicily. 61
31863404 2020

Variations for Acute Stress Disorder

Expression for Acute Stress Disorder

Search GEO for disease gene expression data for Acute Stress Disorder.

Pathways for Acute Stress Disorder

Pathways related to Acute Stress Disorder according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 9.47 CRHR1 CRH

GO Terms for Acute Stress Disorder

Biological processes related to Acute Stress Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 female pregnancy GO:0007565 9.5 OXT CRHR1 CRH
2 memory GO:0007613 9.43 SLC6A4 OXT BDNF
3 parturition GO:0007567 9.16 CRHR1 CRH
4 sperm ejaculation GO:0042713 8.96 SLC6A4 OXT
5 response to ether GO:0045472 8.62 OXT CRH

Sources for Acute Stress Disorder

9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
31 HPO
32 ICD10
33 ICD10 via Orphanet
37 LifeMap
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
54 Novoseek
57 OMIM via Orphanet
61 PubMed
70 Tocris
72 UMLS via Orphanet
Loading form....